The global Pharmaceutical Grade Sodium Chloride Market is entering a transformative decade, poised to grow from an estimated USD 524 million in 2025 to USD 916 million by 2035, registering a steady CAGR of 5.7%. This growth represents an absolute dollar opportunity of USD 392 million and reflects a robust demand trajectory across dialysis treatments, injectable formulations, and advanced pharmaceutical applications.